Viatris (VTRS) Change in Cash (2019 - 2026)
Viatris' (VTRS) quarterly Change in Cash came in at $457.7 million in Q1 2026, up 2165.84% year-on-year from $20.2 million in Q1 2025, and up 32.86% quarter-over-quarter from $344.5 million in Q4 2025.
Viatris (VTRS) Change in Cash (2019 - 2026) Analysis & Trends
Viatris' Change in Cash history runs 8 years deep, the most recent figure standing at $457.7 million for Q1 2026.
- On a quarterly basis, Change in Cash rose 2165.84% year-over-year to $457.7 million in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 504.24% increase from a year earlier, with the FY2025 full-year figure at $611.9 million, up 337.63% from the prior year.
- Change in Cash grew to $457.7 million in Q1 2026 per VTRS's latest filing, from $344.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $961.6 million in Q3 2024 and bottomed at -$1.1 billion in Q4 2024.
- The 5-year median for Change in Cash is $22.3 million (2024), against an average of $64.7 million.
- Biggest YoY gain for Change in Cash was 3681.05% in 2023; the steepest drop was 1568.36% in 2023.
- Year by year, Change in Cash stood at $612.1 million in 2022, then sank by 151.98% to -$318.2 million in 2023, then plunged by 259.52% to -$1.1 billion in 2024, then soared by 130.11% to $344.5 million in 2025, then surged by 32.86% to $457.7 million in 2026.
- Per Business Quant, the three latest VTRS Change in Cash figures stand at $457.7 million (Q1 2026), $344.5 million (Q4 2025), and $435.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 15.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 457.70 Mn |
| Dec 31, 2025 | 344.50 Mn |
| Sep 30, 2025 | 435.70 Mn |
| Jun 30, 2025 | -188.50 Mn |
| Mar 31, 2025 | 20.20 Mn |
| Dec 31, 2024 | -1.14 Bn |
| Sep 30, 2024 | 961.60 Mn |
| Jun 30, 2024 | -97.40 Mn |
| Mar 31, 2024 | 22.30 Mn |
| Dec 31, 2023 | -318.20 Mn |
| Sep 30, 2023 | 680.40 Mn |
| Jun 30, 2023 | 120.70 Mn |
| Mar 31, 2023 | -751.80 Mn |
| Dec 31, 2022 | 612.10 Mn |
| Sep 30, 2022 | -19.00 Mn |
| Jun 30, 2022 | -88.00 Mn |
| Mar 31, 2022 | 51.20 Mn |
| Dec 31, 2021 | -55.50 Mn |
| Sep 30, 2021 | 82.60 Mn |
| Jun 30, 2021 | -134.00 Mn |